Announcement of Lanfan Medical Co., Ltd. Regarding a Plan for Partial Directors and Senior Management to Increase Holdings of Company Shares

Log in to Sina Finance App and search for [Disclosure of Information] to see more evaluation levels.

Stock Code: 002382 Stock Abbreviation: Lanfan Medical Announcement No.: 2026-023

Bond Code: 128108 Bond Abbreviation: Lanfan Convertible Bond

Lanfan Medical Co., Ltd.

Announcement on the Share Purchase Plan by Certain Directors and Senior Management

Chairwoman Liu Wenjing, Director and President Zhong Shuqiao, Director Yu Suhua, Employee Director Zhao Min, Vice President and Chief Financial Officer Cui Yuntao, and Secretary of the Board Wang Ziyi guarantee that the information provided to the company is true, accurate, and complete, with no false records, misleading statements, or major omissions.

The company and all members of the board of directors guarantee that the content of this announcement is consistent with the information disclosed by the information disclosure obligors.

Special Reminder: Based on recognition of the intrinsic value of Lanfan Medical Co., Ltd. (hereinafter referred to as “the Company”) and firm confidence in its future sustained, stable, and healthy development, as well as to protect shareholders’ interests and enhance investor confidence, the company’s chairman Liu Wenjing, director and president Zhong Shuqiao, director Yu Suhua, employee director Zhao Min, vice president and CFO Cui Yuntao, and secretary of the board Wang Ziyi plan to increase their holdings of the company’s shares within one week from the date of this announcement (March 20, 2026, to March 26, 2026), in accordance with relevant laws and regulations. The total amount of this share purchase plan will not be less than RMB 5 million (inclusive).

Recently, the company received notices from Chairman Liu Wenjing, Director and President Zhong Shuqiao, Director Yu Suhua, Employee Director Zhao Min, Vice President and CFO Cui Yuntao, and Secretary of the Board Wang Ziyi, each issuing a “Notice of Share Purchase Plan.” The relevant details are hereby announced as follows:

1. Details of the share purchase

2. Basic information of the purchasing entities: Chairman Liu Wenjing, Director and President Zhong Shuqiao, Director Yu Suhua, Employee Director Zhao Min, Vice President and CFO Cui Yuntao, Secretary of the Board Wang Ziyi.

3. Shareholding status of the purchasing entities:

■

3. The above-mentioned purchasing entities did not disclose any share purchase plans in the past 12 months, and there have been no share reductions in the past 6 months prior to this announcement.

4. Main contents of the purchase plan

5. Purpose of the purchase: Based on recognition of the company’s intrinsic value and confidence in its future sustained, stable, and healthy development, as well as to protect shareholders’ interests and boost investor confidence, the above-mentioned entities plan to increase their holdings of the company’s shares.

6. Quantity or amount of shares to be purchased: The total amount of this purchase plan will not be less than RMB 5 million (inclusive).

7. Purchase price: This purchase plan does not set a price range; it will be implemented based on stock price fluctuations and overall market trends at appropriate times.

8. Implementation period: Considering market fluctuations and capital arrangements, the entities plan to purchase shares within one week from the announcement date (March 20, 2026, to March 26, 2026), unless prohibited by laws, regulations, or Shenzhen Stock Exchange rules. If the stock is suspended during this period, the purchase will be postponed until trading resumes and will be disclosed promptly.

9. Purchase method: The shares will be bought through centralized bidding on the Shenzhen Stock Exchange.

10. Source of funds: The purchase will be financed by self-owned or raised funds.

11. This purchase plan is not based on any specific identity of the entities; if such identity is lost, the plan will continue.

12. Apart from the lock-up period stipulated by relevant rules, there are no other lock-up arrangements.

13. The entities undertaking this plan promise: During the implementation period and within the statutory period, they will not sell their holdings of the company’s shares. They will strictly comply with relevant laws and regulations, complete the purchase within the specified period, and refrain from insider trading, trading during sensitive periods, or short-term trading.

14. Risks and uncertainties in implementing the purchase plan

The implementation of this plan may be delayed or impossible due to changes in capital market conditions or the pace of fund raising. If relevant risks occur during implementation, the company will fulfill its disclosure obligations in a timely manner. Investors are advised to be aware of investment risks.

4. Other relevant notes

5. This purchase complies with the Securities Law and other laws, regulations, departmental rules, and Shenzhen Stock Exchange rules.

6. The implementation of this plan will not affect the company’s listing status, nor will it cause the company’s shareholding structure to fall below listing requirements, nor will it change the controlling shareholder or actual controller.

7. This purchase reflects the confidence of the company’s chairman Liu Wenjing, director and president Zhong Shuqiao, director Yu Suhua, employee director Zhao Min, vice president and CFO Cui Yuntao, and secretary of the board Wang Ziyi in the company’s development prospects and long-term investment value. It does not constitute investment advice. Investors should be aware of investment risks.

8. Supporting documents

Letters of Notification of Share Purchase Plans issued separately by Chairman Liu Wenjing, Director and President Zhong Shuqiao, Director Yu Suhua, Employee Director Zhao Min, Vice President and CFO Cui Yuntao, and Secretary of the Board Wang Ziyi.

This announcement is hereby made.

Lanfan Medical Co., Ltd.

Board of Directors

March 20, 2026